MedPath
HSA Approval

BETADINE SORE THROAT SPRAY 0.45% W/V

SIN15313P

BETADINE SORE THROAT SPRAY 0.45% W/V

BETADINE SORE THROAT SPRAY 0.45% W/V

August 7, 2017

MUNDIPHARMA PHARMACEUTICALS PTE. LTD.

MUNDIPHARMA PHARMACEUTICALS PTE. LTD.

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantMUNDIPHARMA PHARMACEUTICALS PTE. LTD.
Licence HolderMUNDIPHARMA PHARMACEUTICALS PTE. LTD.

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
General Sale List
HSA Singapore Classification

Formulation Information

SPRAY

**How much and how often should you use this medicine?** For use in adults and children over 6 years of age. One spray into the back of the throat every 3–4 hours as needed, to a maximum of three sprays a day.

ORAL

Medical Information

**What is this medicine used for?** **BETADINE** ® **Sore Throat Spray** is indicated for protection and symptomatic relief of sore throat and mouth ulcers. For oral hygiene prior to, during and after dental and oral surgery.

**When should you not take this medicine?** This medicine should be avoided: - If you have an allergy to iodine or any ingredients in **BETADINE** ® **Sore Throat Spray** - If you have a thyroid problem - In children under 6 years of age - If you are to receive or currently receiving radioactive iodine treatments - If you are pregnant or breast feeding

R02AA15

povidone-iodine

Manufacturer Information

MUNDIPHARMA PHARMACEUTICALS PTE. LTD.

Mundipharma Pharmaceuticals Ltd

Active Ingredients

Povidone-Iodine

0.45% w/v

Povidone-iodine

Documents

Patient Information Leaflets

1.4.4 Throat Spray_PIL (Proposed).pdf

Approved: April 21, 2022

Download

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

BETADINE SORE THROAT SPRAY 0.45% W/V - HSA Approval | MedPath